Advertisement
Advertisement

INTS

INTS logo

Intensity Therapeutics Inc

1.93
USD
-0.07
-3.50%
Dec 18, 15:40 UTC -5
Closed
...

Intensity Therapeutics Inc Profile

About

Intensity Therapeutics Inc. is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. Intensity leverages its DfuseRx(SM) technology platform to create new, proprietary drug formulations, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity Therapeutics Inc. is based in WESTPORT, Conn.

Info & Links

CEO

Lewis H. Bender

Headquarters

1 ENTERPRISE DRIVE, SUITE 430
SHELTON, CT 06484, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www.intensitytherapeutics.com

Auditor

EisnerAmper LLP

Share holders

--

Employees

7

Intensity Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

26.77M

Enterprise Value

24.13M

Enterprise Value/EBITDA(ttm)

-1.44

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

10.21

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-209.73%

Return on Invested Capital(ttm)

-282.77%

Return on Assets(ttm)

-149.19%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-16.71M

Net Income Available to Common(ttm)

-16.26M

Diluted EPS(ttm)

-1.07

Share Statistics

Beta (5Y Monthly)

3.61

52-Week Change

-41.52%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

13.87M

Dividend Yield

0.00%

Float4

11.29M

% Held by Insiders

18.60%

% Held by Institutions

3.74%

Balance Sheet

Total Cash(mrq)

2.78M

Total Cash Per Share(mrq)

0.20

Total Debt(mrq)

145.00K

Total Debt/Equity(mrq)

5.22%

Current Ratio(mrq)

1.63%

Quick Ratio(mrq)

1.63%

Book Value Per Share(mrq)

0.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.91

Free Cash Flow(ytd)

-12.55M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement